Erythroplasia

01/01/2002 - "We report the complete clearance of HPV-16-positive erythroplasia of Queyrat with 5% imiquimod cream."
04/01/2019 - "Erythroplasia of Queyrat treated with imiquimod 5% cream: The necessity of regimen guidelines."
01/01/2014 - "Optical coherence tomography imaging of erythroplasia of Queyrat and treatment with imiquimod 5% cream: a case report."
11/01/2009 - "A case of erythroplasia of queyrat treated with imiquimod 5% cream and excision."
11/01/2006 - "Erythroplasia of Queyrat treated with imiquimod 5% cream."

10/01/1976 - "Seven adult men with biopsy-confirmed erythroplasia of Queyrat (EQ) were cured of their disease with topically applied 5-fluorouracil (5-FU) under occlusion. "
09/01/2016 - "Erythroplasia of Queyrat treated with topical 5-fluorouracil."
10/01/1976 - "Erythroplasia of Queyrat: treatment with topical 5-fluorouracil."
06/02/1975 - "Patients with histologically confirmed erythroplasia of Queyrat should be afforded treatment with topically applied fluorouracil, as results appear to be superior to those of surgical or radiological treatment, with less morbidity."
06/02/1975 - "Three patients with biopsy-confirmed erythroplasia of Queyrat were treated with topically applied fluorouracil. "

01/01/2011 - "Methylaminolaevulinic acid photodynamic therapy in the treatment of erythroplasia of Queyrat."
04/01/2000 - "Erythroplasia of queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale."
03/01/1999 - "Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy."
06/01/2023 - "This case suggested that 5-aminolaevulinic acid photodynamic therapy is effective and safe in the treatment of Queyrat erythroplasia, which provides a new choice for the patients with Queyrat erythroplasia with poor therapeutic effect."

06/01/2023 - "This case suggested that 5-aminolaevulinic acid photodynamic therapy is effective and safe in the treatment of Queyrat erythroplasia, which provides a new choice for the patients with Queyrat erythroplasia with poor therapeutic effect."

05/01/1950 - "[Vulvar erythroplasia of 20 years duration, cured in two months by estrogens]."

12/01/2003 - "HPV DNA was positive in 2 (33.3%) of 6 Queyrat erythroplasia cases and all were of HPV16 type. "
09/01/2000 - "Human papillomavirus DNA was detected in all erythroplasia of Queyrat patients and in none of the controls with inflammatory penile lesions. "
01/01/1998 - "The detection of human papillomavirus 16 DNA in erythroplasia of Queyrat invading the urethra."
02/01/1997 - "The results showed that 2(2/17) cases of Bowen's disease, 1 case of Queyrat erythroplasia and 9(9/16) cases of Bowenoid papulosis were positive for HPV16 DNA and that 20 cases of invasive cutaneous sqamous cell carcinoma were negative for HPV16 DNA. "

01/01/2011 - "Besides lesions considered to be premalignant (such as erythroplasia, Bowen disease), a number of other potentially malignant lesions with higher or lower degree of epithelial dysplasia depending on the keratinization degree or determined by the action of carcinogens and irritants substances are described in the oral mucosa. "
04/01/2001 - "The following key words were used and classed into three groups; 1) oral mucosa, epidemiology, precancerous lesions, malignant transformation, dysplasia, leucoplakia, oral lichen planus, erythroplasia, verrucous, cheilitis, candidosis, immunodepression, 2) oral mucosa, tumor markers, carcinogens, keratin, keratinocytes, gene, nuclear proteins, p53 protein, Ki-67 antigen, 3) oral mucosa, therapy, prevention, nutrients. "

09/01/2000 - "Viral load determinations (human papillomavirus copies/beta-globin gene copies) by realtime polymerase chain reactions showed that the human papillomavirus type 16 levels in the erythroplasia of Queyrat biopsies were one to five orders of magnitude higher than the human papillomavirus type 8 levels. "

04/01/2001 - "The following key words were used and classed into three groups; 1) oral mucosa, epidemiology, precancerous lesions, malignant transformation, dysplasia, leucoplakia, oral lichen planus, erythroplasia, verrucous, cheilitis, candidosis, immunodepression, 2) oral mucosa, tumor markers, carcinogens, keratin, keratinocytes, gene, nuclear proteins, p53 protein, Ki-67 antigen, 3) oral mucosa, therapy, prevention, nutrients. "

10/16/1993 - "Erythroplasia of Queyrat treated with isotretinoin."

06/25/2020 - "Efficacy of topical photodynamic therapy in the treatment of Erythroplasia of Queyrat."
05/01/2021 - "Dermoscopic monitoring of erythroplasia of Queyrat treated with photodynamic therapy."
02/01/2020 - "Erythroplasia of Queyrat treated with methyl aminolevulinate-photodynamic therapy."
10/01/2012 - "Erythroplasia of Queyrat refractory to photodynamic therapy."
10/01/2012 - "Methyl-aminolevulinate photodynamic therapy for the treatment of erythroplasia of Queyrat in 23 patients."

04/06/1963 - "[Queyrat's erythroplasia of the penis cured by radiotherapy]."
07/01/1956 - "[Ulcerous erythroplasia of the penis; cure with radiotherapy with corticotherapy; effectiveness of this combined therapy in dermatology]."
10/01/1974 - "[Treatment of Bowen's disease, Bowen's carcinoma and Gueyrat's erythroplasia with special reference to low-voltage radiotherapy]."

04/01/1967 - "[Erythroplasia of Queyrat as a consequence of arsenobenzene therapy]."
07/01/1956 - "[Ulcerous erythroplasia of the penis; cure with radiotherapy with corticotherapy; effectiveness of this combined therapy in dermatology]."
01/01/1994 - "The group at high risk for skin cancer included patients older than 50, with the following pathologies: (I) Obligate precancerous dermatites: Bowen's syndrome, erythroplasia of Queyrat, Paget's disease (extramammary localization), intraepidermal epithelioma of Jadassohn, late-onset radiation dermatitis, early childhood-Kaposi's disease, Manganotti's chilitis and verrucous precancer of the lip; Optional precancerous dermatosis: childhood-onset epidermodysplasia veruciformis, actinic keratosis, cutaneous horn, keratoacanthoma, carcinoid papillomatosis of Gottron, giant condyloma of Buschke-Lowenstein, leukoplakia and limited precancerous hyperkeratosis of the lip's red edge; (2) Dermatoses involving pathological regeneration: eruthematosis, lupus tuberculosis, psoriasis (more than 15 years old), trophic ulcers, extensive scars (particularly, those caused by burns), chronic ulcerative pyoderma and pyoderma vegetans; (3) Hemorrhagic diathesis on the surface or fundus of neoplasm; (4) Consolidation at neoplasm base; (5) Absence of complaints; (6) Resistance to therapy."
01/01/2021 - "Ingenol mebutate therapy in erythroplasia of Queyrat: a new approach."
01/01/1951 - "[Colchicine therapy of erythroplasia]."

12/01/2016 - "Erythroplasia of Queyrat treated by laser and light modalities: a systematic review."
01/01/2017 - "Different approaches have been described in published studies for carcinoma in situ (CIS) of the glans penis (erythroplasia of Queyrat), including topical chemotherapy or immunotherapy and laser or surgical excision. "
08/01/1980 - "Carbon dioxide rapid superpulsed laser treatment of erythroplasia of Queyrat."

01/01/2017 - "Different approaches have been described in published studies for carcinoma in situ (CIS) of the glans penis (erythroplasia of Queyrat), including topical chemotherapy or immunotherapy and laser or surgical excision. "